Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

CTI BIOPHARMA CORP (CTI) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues53.90.00.03.326.325.157.416.1
            Revenue growth  -100.0%-87.3%4.5%-56.2%256.2%-73.2%
Cost of goods sold3.50.00.00.00.00.41.41.9
Gross profit50.40.00.03.326.324.856.014.2
            Gross margin93.5%  100.0%100.0%98.6%97.6%88.0%
Selling, general and administrative84.856.217.619.222.131.445.354.0
Research and development36.939.125.924.136.532.965.076.6
EBIT-79.8-95.3-47.8-39.9-32.2-39.5-49.2-116.7
            EBIT margin-147.9%  -1193.3%-122.6%-157.2%-85.6%-723.9%
Pre-tax income-93.0-97.9-52.5-40.0-29.4-40.8-53.0-120.8
Income taxes0.00.00.00.00.0-0.2-0.9-1.3
            Tax rate0.0%0.0%0.0%0.0%0.1%0.4%1.8%1.1%
Net income-93.0-97.9-52.5-40.0-29.4-45.0-52.0-122.6
            Net margin-172.4%  -1196.4%-111.8%-179.0%-90.6%-760.9%
 
Diluted EPS($0.81)($1.09)($0.74)($0.69)($0.52)($1.24)($1.86)($6.51)
Shares outstanding (diluted)114.790.171.158.056.136.427.918.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy